Harder, Helena http://orcid.org/0000-0002-7296-8227
Shilling, Valerie M.
May, Shirley F.
Cella, David
Schmid, Peter
Fallowfield, Lesley J.
Funding for this research was provided by:
Novartis Pharma AG
Article History
Received: 21 January 2020
Accepted: 11 July 2020
First Online: 27 July 2020
Compliance with ethical standards
:
: P.S. declares consultant/advisory roles for Pfizer, AstraZeneca, Novartis, Roche, Merck, Boehringer Ingelheim, Bayer, Eisai, Celgene, and Puma; D.C. is President of FACIT.org; L.J.F. has received research funding from GSK/Novartis; V.S., S.F.M and H.H. declare no competing interests.
: The research protocol was reviewed and approved by London—City & East Research Ethics Committee (REC reference 14/LO/1939), and the appropriate national health authorities from each international study centre. The trial was conducted in accordance with Good Clinical Practice Guidelines and the Declaration of Helsinki.
: All patients gave written informed consent prior to participation.